Literature DB >> 20957413

The effect of NF-κB pathway on proliferation and apoptosis of human umbilical vein endothelial cells induced by intermittent high glucose.

Gang Chen1, Yufang Chen, Haifeng Chen, Liantao Li, Jin Yao, Qiqin Jiang, Xu Lin, Junping Wen, Lixiang Lin.   

Abstract

Our previous study found that blocking nuclear factor (NF)-κB signaling could protect human umbilical vein endothelial cells (HUVECs) from apoptosis and proliferation inhibition due to high glucose (HG). Intermittent HG makes glucose toxicity more significant. In this study, we aimed to investigate the effect of NF-κB pathway on HUVECs induced by intermittent HG (a daily alternating 5.5 or 30.5 mmol/l glucose). A recombinant adenovirus containing a RNAi cassette targeting the NF-κB/p65 gene was produced, and its silencing effect on p65 gene was detected by Western blot analysis in HUVECs cultured with intermittent HG. The subsequent effect on proliferation of HUVECs in the indicated conditions was measured by the AlamarBlue assay. The Bcl-2 expression was also detected by Western blot. The results showed that the expression of p65 protein could be inhibited efficiently by the RNAi adenovirus. Intermittent HG also induced the translocation of NF-κB in HUVECs. Inhibition of NF-κB with the RNAi adenovirus could prevent the effects. At the 6th day after HUVECs were exposed to intermittent HG, the proliferation of HUVECs with Ad-1566 was significantly higher than that of HUVECs with Ad-DEST (P < 0.01). Knockdown of NF-κB/p65 up-regulated the Bcl-2 expression of HUVECs under intermittent HG conditions (P < 0.01). These findings concluded that the NF-κB/p65-targeting RNAi adenovirus is an important tool, which can efficiently inhibit the expression of p65 gene in HUVECs. Intermittent HG reduces HUVECs proliferation with a concomitant increase in apoptosis. Knockdown of NF-κB/p65 partly protected HUVECs from proliferation inhibition and may reduce apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957413     DOI: 10.1007/s11010-010-0620-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  12 in total

1.  The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles.

Authors:  Helena J M M Mertens; Maas J Heineman; Johannes L H Evers
Journal:  Gynecol Obstet Invest       Date:  2002       Impact factor: 2.031

2.  Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction.

Authors:  Ludovica Piconi; Lisa Quagliaro; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Gianni Zuodar; Antonio Ceriello
Journal:  Diabetes Metab Res Rev       Date:  2006 May-Jun       Impact factor: 4.876

Review 3.  Signalling and chromatin fragmentation in thymocyte apoptosis.

Authors:  D J McConkey; P Nicotera; S Orrenius
Journal:  Immunol Rev       Date:  1994-12       Impact factor: 12.988

Review 4.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

5.  Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Roberto Da Ros; Amabile Maier; Gianni Zuodar; Antonio Ceriello
Journal:  Atherosclerosis       Date:  2005-12       Impact factor: 5.162

6.  High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl.

Authors:  Haikun Li; Sabine Télémaque; Richard E Miller; James D Marsh
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

7.  Ablation of NF-kappaB expression by small interference RNA prevents the dysfunction of human umbilical vein endothelial cells induced by high glucose.

Authors:  Gang Chen; Xiaoyan Shen; Jin Yao; Feng Chen; Xu Lin; Yufang Qiao; Tingting You; Fenghui Lin; Xiaowen Fang; Xin Zou; Lixiang Lin
Journal:  Endocrine       Date:  2008-11-08       Impact factor: 3.633

8.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.

Authors:  Lisa Quagliaro; Ludovica Piconi; Roberta Assaloni; Lucia Martinelli; Enrico Motz; Antonio Ceriello
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.

Authors:  Ludovica Piconi; Maddalena Corgnali; Roberto Da Ros; Roberta Assaloni; Teodoro Piliego; Antonio Ceriello
Journal:  J Diabetes Complications       Date:  2008 Jan-Feb       Impact factor: 2.852

View more
  3 in total

1.  Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo.

Authors:  Chunmei Wang; Guangyao Sheng; Jie Lu; Lei Xie; Songting Bai; Yingchao Wang; Yufeng Liu
Journal:  Mol Cell Biochem       Date:  2011-09-07       Impact factor: 3.396

2.  The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells.

Authors:  Zhen Zhang; Jing Li; Lei Yang; Rongping Chen; Rui Yang; Hua Zhang; Dehong Cai; Hong Chen
Journal:  J Diabetes Res       Date:  2014-03-17       Impact factor: 4.011

3.  CRISPR/Cas9-mediated gene knockout reveals a guardian role of NF-κB/RelA in maintaining the homeostasis of human vascular cells.

Authors:  Ping Wang; Zunpeng Liu; Xiaoqian Zhang; Jingyi Li; Liang Sun; Zhenyu Ju; Jian Li; Piu Chan; Guang-Hui Liu; Weiqi Zhang; Moshi Song; Jing Qu
Journal:  Protein Cell       Date:  2018-07-02       Impact factor: 14.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.